Multimodal treatments for resectable esophagogastric junction cancer: a systematic review and network meta-analysis.

ABSTRACT:

Background

Currently, preoperative chemoradiotherapy, perioperative chemotherapy and preoperative chemotherapy are recommended by NCCN, ESMO and Japanese guidelines respectively for resectable esophageal and junctional cancer. However, these recommendations are mainly based on esophageal cancer research. Therefore, specific for esophagogastric junction cancer, we conducted the first systematic review and network meta-analysis to rank all potential treatments simultaneously and hierarchically.

Methods

Record retrieval was conducted in PubMed, Web of Science, Cochrane Central Register of Controlled Trials, Embase, ASCO and ESMO Meeting Library from inception to September 2018. Regarding time-to-event survival data, randomized controlled trials featuring comparisons between dif

SUBMITTER: Cheng J 

PROVIDER: S-EPMC6446435 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature